US2012226031A1PendingUtilityA1

Palmarumycin based inhibitors of thioredoxin and methods of using same

Assignee: POWIS GARTHPriority: Sep 15, 2005Filed: Feb 2, 2012Published: Sep 6, 2012
Est. expirySep 15, 2025(expired)· nominal 20-yr term from priority
A61K 31/357A61P 35/00C07D 319/08A61K 31/7048
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Embodiments of the present invention relate to inhibitors of thioredoxin. Certain embodiments relate to palmarumycin based compounds and methods of using the same. Such compounds may be useful in inhibiting the overexpression of thioredoxin, inhibiting tumor growth and treating cancer.

Claims

exact text as granted — not AI-modified
1 - 15 . (canceled) 
     
     
         16 . A compound, or salt thereof, having the general formula: 
       
         
           
           
               
               
           
         
         wherein 
         R 1  is H or OH; 
         R 2  is selected from the group consisting of O(CH 2 )nCH 3 , OCH(CH 3 )CHnCH 3 , OCH 2 CH 2 -morpholino, OC(O)CH 2 NH 2 , and OC(O)CH(CH(CH 3 ) 2 )NH 2 , OC(O)CH(CH 3 )NH 2 , OC(O)CH(CH 2 Phenyl)NH 2 , OC(O)CH(CH 2  p-OHPhenyl)NH 2   
       
       
         
           
           
               
               
           
         
       
       OC(O)CH(CH 2 OH)NH 2 , OC(O)CH(CH 2 SH)NH 2 , OC(O)CH(CH 2 COOH)NH 2 , OC(O)CH(CH 2 CH 2 COOH)NH 2 , OC(O)CH(CH 2 CONH 2 )NH 2 , OC(O)CH(CH 2 CH 2 CONH 2 )NH 2 , OC(O)CH(CH(CH 3 )CH 2 CH 3 )NH 2 , OC(O)CH(CH 2 CH(CH 3 ) 2 )NH 2 , OC(O)CH(CH(OH)CH 3 )NH 2 ; and 
       
         
           
           
               
               
           
         
         n is 1-4, and 
         R 3  is hydrogen, or NHNHC(CH 3 ) 2 CONH 2 , 
            represents the option of having a double bond.

Join the waitlist — get patent alerts

Track US2012226031A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.